These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V. Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [Abstract] [Full Text] [Related]
3. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
8. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice. Greenberger JS, Shadduck RK, Jaenisch R, Waheed A, Sakakeeny MA. Cancer Res; 1981 Sep 15; 41(9 Pt 1):3556-65. PubMed ID: 6266658 [Abstract] [Full Text] [Related]
9. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells. Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V. Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323 [Abstract] [Full Text] [Related]
10. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ. Exp Hematol; 1996 Feb 15; 24(2):185-94. PubMed ID: 8641340 [Abstract] [Full Text] [Related]
11. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
12. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781 [Abstract] [Full Text] [Related]
20. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Bruno E, Luikart SD, Long MW, Hoffman R. Exp Hematol; 1995 Oct 15; 23(11):1212-7. PubMed ID: 7556532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]